Intravitreal bevacizumab as an adjunctive therapy before diabetic vitrectomy
Ashraf M El-BatarnyAssistant Professor of Ophthalmology, Tanta University, Egypt; Chief of Vitreoretinal Service, Magrabi Eye and Ear Hospital, Muscat, Sultanate of OmanPurpose: To evaluate the effect of intravitreal injection of Avastin, bevacizumab (IVA) on diabetic vitrectomy and on the postopera...
Guardado en:
Autor principal: | Ashraf M El-Batarny |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7671c2dab229430a910ca56cc86a9e04 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Combined intravitreal bevacizumab and photodynamic therapy with vertiporfin for management of choroidal neovascularization secondary to age-related macular degeneration
por: Mamdouh M Kabeel, et al.
Publicado: (2008) -
Effect of initial retinal thickness on outcome of intravitreal bevacizumab therapy for diabetic macular edema
por: Mushtaq B, et al.
Publicado: (2014) -
Effect of intravitreal bevacizumab on diabetic macular edema with hard exudates
por: Jeon S, et al.
Publicado: (2014) -
Transconjunctival sutureless vitrectomy with tissue plasminogen activator, gas and intravitreal bevacizumab in the management of predominantly hemorrhagic age-related macular degeneration
por: Luis Arias, et al.
Publicado: (2010) -
Case of endophthalmitis following intravitreal injections of bevacizumab
por: Shinya Komori, et al.
Publicado: (2010)